Abiomed Inc (ABMD)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

22 CHERRY HILL DR DANVERS, MA 01923

ABIOMED is a provider of mechanical circulatory support devices and it provides a range of care in heart recovery to heart failure patients. Co. develops, manufactures and markets products that are used in the cardiac catheterization lab, or cath lab, by cardiologists and in the heart surgery suite by heart surgeons for patients who require hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. Co.'s products include: the Impella 2.5 catheter, the Impella 5.0 catheter, Impella LD, AB5000 Circulatory Support System, the BVS 5000 Biventricular Support System, and AbioCor implantable replacement heart.

Data based on most recent fiscal year report
Market Cap12.296 Billion Shares Outstanding44.22 Million Avg Volume551.582 Thousand
1-Yr BETA vs S&P TR Current Ratio4.7 Quick Ratio4.19
View SEC Filings from ABMD instead.
Q2 2019 All Institutions Hedge Funds 1
To trade ABMD now:
Filers who had this stock in their top 10: 4 1 (0.1%)
13F Filers holding this stock: 468 41 (4.24%)
Aggregate 13F shares on 06/30/2019: 41.297 Million 4.711 Million
Aggregate 13F shares on 03/31/2019: 39.333 Million 4.973 Million
Percent change: 4.99% -5.27%
Funds creating new positions: 44 2
Funds Adding to an existing position: 180 20
Funds closing out their position: 105 18
Funds reducing their position: 183 17
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ABMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GREENFIELD ANDREW J VP, CHIEF COMMERCIAL OFFICER

  • Officer
51,134 2019-09-30 5

HOWLEY MICHAEL G VP, GLOBAL SALES & MARKETING

  • Officer
53,202 2019-09-30 4

MINOGUE MICHAEL R CHAIRMAN, PRESIDENT, CEO

  • Officer
  • Director
500,198 2019-09-30 6

PUHY DOROTHY E

  • Director
23,981 2019-08-15 1

SUTTER MARTIN P

  • Director
188,939 2019-08-07 6

ROSE ERIC A MD

  • Director
14,236 2019-08-07 1

THOMAS PAUL

  • Director
12,920 2019-08-07 1

VAN GORDER CHRIS

  • Director
6,621 2019-08-07 3

RIVET JEANNINE M

  • Director
7,999 2019-08-07 1

WEBER DAVID M CHIEF OPERATING OFFICER

  • Officer
140,315 2019-08-05 6

TRAPP TODD A VICE PRESIDENT, CFO

  • Officer
7,133 2019-05-30 2

BOLT WILLIAM J SVP, QA AND REGULATORY AFFAIRS

  • Officer
61,381 2019-05-24 3

TOMSICEK MICHAEL JOHN

  • Director
0 2019-05-08 0

DOLLENS RONALD W

  • Director
19,552 2019-01-02 0

MCLEOD IAN VP, CORPORATE CONTROLLER

  • Officer
7,079 2018-02-28 0

TERMEER HENRI A

  • Director
345,533 2016-08-09 0

AUSTEN W GERALD

  • Director
87,241 2015-08-12 0

BOWEN ROBERT CHIEF FINANCIAL OFFICER

  • Officer
76,265 2015-05-15 0

LATAIF LOUIS E

  • Director
111,175 2015-04-29 0

O CONNELL DESMOND JR

  • Director
67,062 2011-04-01 0

ABIOMED INC

  • 10% Owner
No longer subject to file 2010-03-24 0

SUTHERBY DANIEL J CFO, CAO

  • Officer
43,354 2008-09-16 0

FITCH PATRICIA A. VICE PRESIDENT OF SALES

  • Officer
5,000 2008-05-23 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HOWLEY MICHAEL G - Officer VP, GLOBAL SALES & MARKETING

2019-09-30 A 90 a 32,692 53,202.00 direct

MINOGUE MICHAEL R - Director - Officer CHAIRMAN, PRESIDENT, CEO

2019-09-30 A 8 a 237,716 500,198.00 direct

GREENFIELD ANDREW J - Officer VP, CHIEF COMMERCIAL OFFICER

2019-09-30 A 44 a 39,102 51,134.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments